Dallas, TX & Brentwood, TN – [Current Date] – In a landmark development set to redefine the landscape of patient care in orthotics, prosthetics, and complex rehabilitation technology, Hanger Inc., a leading provider of orthotic and prosthetic (O&P) patient care services, has announced its strategic acquisition of Numotion, a prominent provider of complex rehabilitation technology (CRT) and mobility products and services. This transformative combination will give rise to "Hanger Numotion," a formidable North American platform poised to serve an astounding 1.5 million patients annually across the United States and Canada.
The unprecedented merger is designed to create a scaled and integrated continuum of care, uniting Hanger’s extensive network of O&P clinics with Numotion’s specialized expertise in CRT and mobility solutions. This strategic alignment aims to enhance patient access to a comprehensive suite of services, foster significant investment in clinical talent, and accelerate product innovation, ultimately empowering individuals to live with greater mobility and independence. The transaction, structured as a cash acquisition of Numotion by Hanger, will see Patient Square Capital assume control of the newly formed entity, signaling a robust commitment to long-term growth and patient-centric advancements.
Main Facts of the Landmark Acquisition
The convergence of Hanger and Numotion represents a pivotal moment for the rehabilitative and mobility solutions sector. The core tenets of this strategic transaction are multifaceted, designed to leverage the distinct strengths of both organizations while forging a unified vision for the future of patient care.
The Strategic Combination: At its heart, this acquisition is about synergy. Hanger, with its deep roots and extensive clinical footprint in orthotics and prosthetics, brings unparalleled expertise in custom-fabricated devices that restore function and improve quality of life. Numotion, a portfolio company of AEA Investors, specializes in complex rehabilitation technology, including custom power wheelchairs, manual wheelchairs, and adaptive seating, along with essential mobility products and services. The combined entity will bridge critical gaps in patient journeys, ensuring that individuals requiring O&P services can seamlessly access complementary CRT and mobility solutions, and vice versa. This integration promises a more holistic and efficient care pathway, reducing fragmentation and optimizing outcomes for patients with diverse and often intersecting needs.
Services and Scope: The newly formed Hanger Numotion will offer an expansive portfolio of services spanning three crucial domains: Orthotics and Prosthetics (O&P), Complex Rehabilitation Technology (CRT), and broader mobility and independence solutions. This comprehensive approach means that whether a patient requires a custom prosthetic limb, a brace for support, a specialized power wheelchair, or adaptive home modifications, Hanger Numotion will be equipped to provide integrated solutions. The breadth of services under one umbrella is a game-changer, simplifying the often-complex process of navigating different providers for various rehabilitative needs. The focus remains on empowering individuals to achieve their maximum functional independence, addressing both their physical and lifestyle requirements.
Financial and Ownership Structure: The transaction is structured as an acquisition of Numotion for cash by Hanger. While the specific financial terms of the deal were not disclosed in the initial announcement, the involvement of Patient Square Capital as the controlling entity underscores the significant investment and strategic backing behind this merger. Patient Square Capital, known for its focused investments in the healthcare sector, is poised to provide the necessary capital and strategic guidance to support the combined company’s ambitious growth objectives, technological advancements, and expansion initiatives. This ownership structure suggests a long-term vision, prioritizing sustainable development and value creation through enhanced patient care and operational excellence.
Leadership Transition: A key aspect of the integration plan involves a strategic leadership transition. Upon the close of the transaction, Mike Swinford, the current CEO of Numotion, will assume the role of CEO for the combined Hanger Numotion entity. Swinford brings a wealth of experience, having successfully led Numotion since 2014, steering the company through a period of significant growth, diversification, and market expansion to establish it as a mobility leader. His extensive background, including over two decades at GE and a tenure as President and CEO of GE Healthcare Services, positions him uniquely to guide this newly formed enterprise. Pete Stoy, the current CEO of Hanger Inc., expressed his full confidence in Swinford’s leadership, acknowledging his commitment to patients and people, and his ability to build on Hanger’s momentum.
Geographic Footprint and Patient Impact: The scale of the combined operation is truly impressive. Hanger currently operates approximately 925 U.S.-based O&P clinics, providing a vast network of patient care centers across the nation. Numotion contributes over 200 locations spanning North America, including both the U.S. and Canada, specializing in CRT and mobility services. This expansive geographic footprint will enable Hanger Numotion to serve more than 1.5 million patients annually. The sheer reach of this combined network significantly enhances access to specialized care, particularly in regions where integrated O&P and CRT services may have been fragmented or less accessible. It promises to deliver a consistent standard of high-quality care across a broad demographic and geographic spectrum.
A Timeline of Strategic Evolution and Anticipation
The journey towards the formation of Hanger Numotion is rooted in the individual histories of two market leaders, culminating in a strategic alignment driven by market needs and a shared vision for patient empowerment. The timeline leading up to and following this announcement is crucial for understanding the depth and foresight behind this monumental merger.
Background of Hanger: Hanger Inc. boasts a long and storied history, establishing itself as a pioneer and a leader in the orthotics and prosthetics industry. For decades, Hanger has been synonymous with innovation and compassionate patient care, providing custom-designed O&P devices that enable individuals to regain mobility and lead fulfilling lives. Over recent years, particularly since Pete Stoy joined in 2020, Hanger has undergone a significant transformation, evolving into a more integrated national platform. This period saw meaningful investments in its workforce, technology, and clinical capabilities, solidifying its position for sustained growth and preparing it for strategic expansion opportunities such as the Numotion acquisition. Hanger’s commitment to clinical excellence and patient outcomes has been a cornerstone of its operations, building a reputation of trust and reliability within the healthcare community.
Numotion’s Journey to Market Leadership: Numotion, under the stewardship of AEA Investors, has carved out a distinct and powerful niche in the complex rehabilitation technology (CRT) and mobility sector. Since its inception, Numotion has focused on providing personalized mobility solutions, understanding that each patient’s needs are unique and require specialized attention. The company’s growth strategy has involved expanding its geographic reach, diversifying its product and service offerings, and consistently investing in its clinical and technical teams. Mike Swinford, since taking the helm in 2014, has been instrumental in scaling Numotion, transforming it into a formidable leader known for its comprehensive approach to complex mobility challenges, serving thousands of individuals who rely on advanced equipment for daily living.
The Road to the Acquisition Announcement: While the details of the negotiations remain private, the strategic rationale for such a combination has been evident in the evolving healthcare landscape. The increasing recognition of the interconnectedness of O&P and CRT services, coupled with the growing demand for integrated care models, likely provided the impetus for discussions between Hanger and Numotion. Both companies, operating in adjacent yet distinct segments, would have recognized the immense potential in combining their strengths to offer a truly end-to-end solution. The due diligence process would have been extensive, evaluating not just financial metrics but also cultural fit, operational synergies, and the alignment of patient care philosophies. The involvement of Patient Square Capital as the controlling investor suggests a thorough strategic review that identified significant long-term value in this integration.
Anticipated Closing and Future Milestones: The transaction is currently projected to close in the fourth quarter of 2026. This extended timeline, while seemingly distant, is typical for mergers of this scale and complexity, especially within the healthcare sector. The period leading up to the closing will involve a myriad of crucial steps, including securing necessary regulatory approvals, particularly from antitrust authorities, to ensure fair competition in the market. Furthermore, extensive integration planning will be undertaken, encompassing operational alignment, IT systems integration, human resources strategies, and the careful merging of clinical protocols. This pre-closing phase will be critical in laying the groundwork for a smooth transition, ensuring that Hanger and Numotion can hit the ground running as a unified entity, maintaining continuity of care for their vast patient base. The prolonged period also allows for careful communication with employees, patients, and stakeholders, fostering understanding and buy-in for the future vision of Hanger Numotion.
The Data Behind the Deal: Market Dynamics and Synergies
The strategic rationale underpinning the Hanger-Numotion merger is deeply rooted in compelling market dynamics and the promise of significant operational and clinical synergies. This combination is not merely an aggregation of assets but a deliberate move to create a more resilient, innovative, and patient-centric enterprise.
Market Size and Growth in O&P and CRT: The orthotics and prosthetics market, alongside complex rehabilitation technology, represents a substantial and growing segment within healthcare. Factors such as an aging global population, rising incidence of chronic diseases (e.g., diabetes leading to amputations), traumatic injuries, and congenital conditions contribute to a continuous demand for O&P devices and CRT solutions. Advancements in medical science and technology also mean that more individuals are surviving and thriving with conditions that previously limited their mobility, thereby increasing the need for sophisticated rehabilitative aids. The combined market for these services is estimated to be in the tens of billions of dollars annually, with consistent growth projected over the next decade. This growth trajectory provides a fertile ground for a scaled entity like Hanger Numotion to expand its reach and impact.
Complementary Capabilities and Service Integration: The most powerful data point supporting this merger is the inherent complementarity of Hanger and Numotion’s services. Patients often require both O&P and CRT solutions at different stages of their rehabilitation journey, or even concurrently. For instance, an individual with a lower limb amputation may need a prosthetic limb (O&P) and also a specialized wheelchair for certain situations, or adaptive seating for comfort and pressure relief (CRT). Historically, navigating these needs often meant dealing with multiple providers, disparate billing systems, and fragmented care plans. Hanger Numotion eliminates these silos, offering a seamless continuum of care. This integration allows for:
- Holistic Patient Assessment: Clinicians can consider the full spectrum of a patient’s mobility needs.
- Coordinated Care Plans: Development of unified treatment strategies.
- Streamlined Logistics: Better coordination of device delivery, fitting, and follow-up.
- Enhanced Data Sharing: Improved communication between O&P clinicians and CRT specialists.
This integrated approach is not just convenient; it’s clinically superior, leading to better outcomes and a more positive patient experience.
Operational Scale and Efficiency Gains: The combined entity will immediately benefit from economies of scale. With a larger operational footprint, Hanger Numotion can achieve greater efficiency in several key areas:
- Procurement: Leveraging increased purchasing power for raw materials, components, and technology, potentially leading to cost savings that can be reinvested in patient care or innovation.
- Logistics and Distribution: Optimizing supply chains for devices and materials across a wider network, reducing delivery times and operational costs.
- Administrative Functions: Consolidating back-office operations, IT infrastructure, and billing systems, leading to streamlined processes and reduced overhead.
- Talent Acquisition and Development: A larger, more diverse organization can attract top talent, offer broader career pathways, and invest more significantly in professional development and cross-training for its clinicians and technicians.
These efficiencies translate into a more robust and financially stable organization, capable of sustaining long-term investments in its people, technology, and patient services.
Investment in Innovation and Clinical Excellence: The combined scale and resources of Hanger Numotion are expected to fuel significant advancements in innovation and clinical practice. This includes:
- Research and Development (R&D): Increased capacity to invest in cutting-edge research for advanced prosthetic components, orthotic materials, smart mobility devices, and adaptive technologies. This could involve exploring areas like AI-powered prosthetics, robotic exoskeletons, or next-generation custom seating solutions.
- Technology Adoption: Faster integration of new technologies, such as 3D printing for custom devices, advanced scanning techniques for precise measurements, and telehealth platforms for remote consultations and follow-ups.
- Clinical Training and Education: Development of enhanced training programs for O&P practitioners and CRT specialists, promoting cross-disciplinary knowledge and elevating the overall standard of care. This also includes attracting and retaining highly skilled clinicians, offering them unparalleled opportunities for professional growth.
Patient Access and Advocacy: With over 1,125 locations across North America, Hanger Numotion will dramatically expand patient access to specialized care. This is particularly vital in underserved rural areas or communities where access to both O&P and CRT specialists may be limited. A larger, more influential organization also has a stronger voice in advocating for patient rights, improved reimbursement policies, and greater awareness of the benefits of rehabilitative technologies with policymakers and insurance providers. Their collective expertise and patient data can contribute to better public health outcomes and more equitable access to life-changing mobility solutions.
Voices from the Helm: Official Responses and Vision
The announcement of Hanger’s acquisition of Numotion has been met with significant enthusiasm from the leadership of both companies, who articulated a shared vision for the future and underscored the profound potential of their combined efforts.
Mike Swinford’s Vision for Hanger Numotion: Mike Swinford, who will lead the combined entity as CEO, articulated a clear and inspiring vision for Hanger Numotion. He emphasized the fundamental philosophical alignment between the two organizations: "Our two companies share a fundamental belief in the role mobility can play in improving people’s lives." This core principle will serve as the guiding star for the new organization, ensuring that every strategic decision and operational initiative is centered on enhancing patient mobility and independence. Swinford highlighted the opportunity to "build on each company’s strengths and help more people across their mobility journeys," suggesting a synergistic approach that leverages the best practices and innovations from both Hanger and Numotion.
His remarks also included a gracious acknowledgment of the partners who have been instrumental in Numotion’s success. He personally thanked Pete Stoy for his outstanding leadership at Hanger, AEA Investors for their strong partnership and commitment as Numotion’s primary investor, and LLR for its longstanding investment and support. This recognition not only demonstrates professionalism but also signals a commitment to collaborative transitions and the appreciation of past contributions. Swinford’s forward-looking statement, "I look forward to working with teams across Hanger, Numotion, and Patient Square as we bring our organizations together and advance our shared commitment to helping people live with greater mobility and independence," conveys a readiness to lead and integrate, fostering a unified culture focused on the patient.
Pete Stoy’s Reflection and Endorsement: Pete Stoy, the outgoing CEO of Hanger Inc., shared his profound pride in the accomplishments of his team and the significant transformation Hanger has undergone during his tenure since 2020. His statement, "Together, we have built a stronger, more integrated national platform, invested meaningfully in our people, technology, and capabilities, and positioned Hanger for sustained growth," reflects a successful strategic repositioning that has culminated in this landmark acquisition. Stoy’s confidence in Mike Swinford’s ability to lead the combined company was unequivocal. He stated, "I have worked with Mike closely throughout this process, and I have tremendous confidence in his ability to lead Hanger Numotion… He is an accomplished leader who shares our commitment to patients and our people, and I believe he is well-positioned to build on Hanger’s momentum and realize the tremendous potential of the combined organization ahead." This strong endorsement from the departing leader is crucial for a smooth transition, reassuring employees, investors, and patients of the future leadership’s capabilities and shared values.
The Perspective of Patient Square Capital: While specific statements from Patient Square Capital were not immediately available, their role as the controlling entity in the combined company speaks volumes about their strategic vision. Patient Square Capital is a healthcare-focused investment firm, and their involvement signals a belief in the long-term growth potential of the O&P and CRT markets, as well as the inherent value in creating an integrated care platform. Their investment typically implies a strategic commitment to fostering innovation, driving operational efficiencies, and expanding market reach. Patient Square Capital’s oversight will likely focus on leveraging the combined resources to accelerate technological adoption, enhance clinical outcomes, and optimize the patient experience, ensuring that Hanger Numotion remains at the forefront of the rehabilitative and mobility solutions industry. Their investment philosophy often involves empowering strong management teams, and their trust in Mike Swinford’s leadership aligns with this approach.
Industry and Investor Reactions: The industry’s reaction to such a significant consolidation is likely to be a mix of anticipation and strategic re-evaluation. Competitors will undoubtedly be observing closely, considering their own strategies in response to the emergence of a larger, more integrated player. Investors, particularly those focused on the healthcare sector, will likely view the merger as a positive development, given the potential for increased market share, enhanced profitability through synergies, and a stronger competitive position. The long closing period also allows the market to digest the implications and adjust expectations, signaling a thoughtful and deliberate approach to this major transaction.
Far-Reaching Implications: Shaping the Future of Rehabilitation and Mobility
The formation of Hanger Numotion is not merely a corporate transaction; it carries profound implications that will resonate across the healthcare ecosystem, impacting patients, professionals, competitors, and the very trajectory of rehabilitation technology.
Impact on Patients and Care Delivery: For the 1.5 million patients Hanger Numotion will serve annually, the most significant implication is the potential for a dramatically improved continuum of care. The integrated platform promises a more streamlined, less fragmented patient journey. Instead of navigating separate providers for a prosthetic limb and a complex wheelchair, patients can potentially access coordinated care, leading to:
- Simplified Access: A single point of contact or referral for a wider range of mobility needs.
- Integrated Solutions: Devices and services that work together harmoniously for better overall function.
- Reduced Administrative Burden: Less paperwork, fewer insurance complexities, and coordinated scheduling.
- Improved Outcomes: Holistic care planning often leads to better long-term functional results and enhanced quality of life.
The commitment to investment in clinicians and innovation also suggests that patients will benefit from access to highly skilled professionals and cutting-edge technologies.
Consequences for the Competitive Landscape: The emergence of Hanger Numotion creates a dominant force in the North American O&P and CRT markets. This consolidation will undoubtedly reshape the competitive landscape. Smaller, independent providers may face increased pressure to differentiate their services, specialize further, or explore strategic partnerships themselves. The larger scale of Hanger Numotion could allow for more aggressive market expansion, greater influence in payer negotiations, and a stronger ability to invest in marketing and outreach. This may spur further consolidation within the industry as other players seek to achieve similar economies of scale and comprehensive service offerings to remain competitive.
Opportunities for Clinical Professionals and Workforce Development: For the thousands of orthotists, prosthetists, physical therapists, occupational therapists, and rehabilitation technology suppliers (RTS) working within both organizations, the merger presents significant opportunities. The combined entity can offer:
- Broader Career Pathways: Opportunities for cross-training, specialization in integrated care, and advancement within a larger organization.
- Enhanced Training and Education: Investment in advanced clinical education, research opportunities, and exposure to a wider array of patient cases and technologies.
- Collaborative Practice: Fostering interdisciplinary collaboration between O&P and CRT specialists, leading to a richer learning environment and more comprehensive patient solutions.
- Attraction of Top Talent: The prestige and resources of a market-leading company can attract and retain the best clinical and technical talent, further elevating the standard of care.
Technological Advancement and R&D Potential: The increased resources under Patient Square Capital’s control are expected to significantly accelerate technological advancements in the field. This could include:
- Faster Adoption of New Technologies: Rapid integration of innovations like advanced sensor technology in prosthetics, smart rehabilitation equipment, and AI-driven assessment tools.
- Dedicated R&D Initiatives: Investment in developing proprietary solutions that address unmet patient needs, pushing the boundaries of what’s possible in mobility.
- Data-Driven Insights: Leveraging a vast patient dataset to inform research, improve device design, and personalize care even further.
The synergy between O&P and CRT expertise can also foster innovation at their intersection, creating truly integrated mobility systems.
Regulatory Considerations and Market Consolidation: Given the scale of this acquisition, it is highly likely to undergo rigorous scrutiny from regulatory bodies, particularly regarding antitrust implications. The long closing period until Q4 2026 suggests that both companies and Patient Square Capital are preparing for a thorough review process. Regulators will assess whether the merger could lead to undue market concentration, limit consumer choice, or impact pricing. Beyond antitrust, a larger entity may also have greater influence in advocating for policy changes related to reimbursement, accessibility standards, and technological adoption, potentially shaping the future regulatory environment for the entire industry.
Economic and Investment Outlook: From an economic perspective, the merger represents a significant investment in the healthcare sector, specifically in areas critical for quality of life. The enhanced operational efficiency, market reach, and innovation potential are expected to generate long-term value for investors. For the broader economy, it signifies growth in a specialized healthcare segment, potentially leading to job creation in R&D, manufacturing, and clinical services, even as administrative functions might be streamlined. The success of Hanger Numotion could also attract further investment into the rehabilitative technology space, signaling confidence in its future growth and importance.
In conclusion, the acquisition of Numotion by Hanger, culminating in the formation of Hanger Numotion, marks a transformative moment. It promises to create a comprehensive, patient-centric platform poised to significantly enhance mobility and independence for millions across North America, setting a new benchmark for integrated care in the orthotics, prosthetics, and complex rehabilitation technology sectors. The journey ahead, while complex, holds immense potential for innovation, expanded access, and improved patient outcomes.
